Animal and cell study links CBD-rich extract with fewer UVB tumours

Full-spectrum cannabidiol-rich extract prevents UVB-induced skin carcinogenesis by suppressing CB1/CB2/GPR55 signalling and COX-2/IL-6 inflammatory pathways.

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology • • Highly Relevant
🤖

AI Summary

The study asked whether a full-spectrum cannabidiol-rich extract (FS-CBD) could limit UVB-related skin cancer development. Researchers tested it in UVB-exposed HaCaT skin cells and CD-1 et/et mice; this was laboratory and animal research, not a human trial. In mice, UVB exposure was associated with an 80% increase in tumour incidence compared with control treatment. FS-CBD pretreatment was associated with tumour incidence of 20%, which the abstract describes as a 75% reduction. Tumour number and size also decreased by approximately 50%.

In the cell experiments, UVB increased CB1 and CB2 expression and reduced GPR55 expression; FS-CBD attenuated these changes and restored GPR55 expression. In mice, treatment was also accompanied by lower detection of these receptors and of the inflammatory markers COX-2 and IL-6. Longer pretreatment was associated with increased epidermal cell death and less frequent malignant transformation. These findings suggest possible chemopreventive effects in the tested models, but this abstract-based summary cannot establish that FS-CBD prevents skin cancer in people, or determine its safety or effectiveness in humans.

💡 Key Findings

1
In CD-1 et/et mice, UVB treatment was associated with an 80% increase in tumour incidence versus control; FS-CBD pretreatment was associated with incidence of 20%, described as a 75% reduction.
Moderate
50%
2
Tumour multiplicity and size decreased by approximately 50% with FS-CBD pretreatment in the mouse model.
Moderate
50%
3
In HaCaT cells and mouse skin, FS-CBD was associated with changes in CB1, CB2, and GPR55 expression, and reduced detection of COX-2 and IL-6 in mice.
Moderate
45%
4
Longer FS-CBD pretreatment was associated with increased epidermal apoptosis and a lower frequency of malignant transformation in the mouse model.
Moderate
40%

📄 Original Abstract

This study aimed to evaluate whether full-spectrum cannabidiol-rich extract (FS-CBD) prevents UVB-induced skin carcinogenesis through the modulation of endocannabinoid receptors and inflammatory pathways in HaCaT keratinocytes and CD-1 et/et mice. In vitro, UVB exposure increased cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2) expression by approximately 83% and decreased G protein-coupled receptor 55 (GPR55) expression. FS-CBD attenuated the upregulation and restored GPR55 expression to approximately four times the value measured after UVB exposure alone. In vivo, compared with the control treatment, UVB treatment resulted in an 80% increase in tumour incidence, while FS-CBD pretreatment for 2 h reduced the incidence to 20%, corresponding to a 75% reduction. Tumour multiplicity and size decreased by approximately 50%, accompanied by significant reductions in the immunodetection of CB1, CB2, GPR55, COX-2, and IL-6, as assessed by confocal microscopy. Notably, prolonged FS-CBD pre-treatment was associated with a marked increase in epidermal apoptosis, displaying a moderate-intensity, multifocal-to-diffuse pattern, which coincided with a lower frequency of malignant transformation. Overall, these findings suggest that FS-CBD pre-treatment may have chemopreventive potential against UVB-induced skin carcinogenesis.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.